(Q73636753)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11257390%20AND%20SRC:MED&resulttype=core&format=json

5 November 2019

title

The B cell targeted adjuvant, CTA1-DD, exhibits potent mucosal immunoenhancing activity despite pre-existing anti-toxin immunity (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11257390%20AND%20SRC:MED&resulttype=core&format=json

5 November 2019

1 reference

1

N Lycke

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11257390%20AND%20SRC:MED&resulttype=core&format=json

5 November 2019

author name string

K Schön

series ordinal

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11257390%20AND%20SRC:MED&resulttype=core&format=json

5 November 2019

language of work or name

English

0 references

publication date

1 March 2001

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11257390%20AND%20SRC:MED&resulttype=core&format=json

5 November 2019

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11257390%20AND%20SRC:MED&resulttype=core&format=json

5 November 2019

volume

19

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11257390%20AND%20SRC:MED&resulttype=core&format=json

5 November 2019

issue

17-19

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11257390%20AND%20SRC:MED&resulttype=core&format=json

5 November 2019

page(s)

2542-2548

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11257390%20AND%20SRC:MED&resulttype=core&format=json

The B-cell system of human mucosae and exocrine glands

5 November 2019

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2800%2900487-4

7 January 2021

The anatomical basis of intestinal immunity

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2800%2900487-4

7 January 2021

Optimism over vaccines administered via mucosal surfaces.

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2800%2900487-4

7 January 2021

Antigen presentation by intestinal epithelial cells

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2800%2900487-4

7 January 2021

Oral vaccination with immune stimulating complexes.

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2800%2900487-4

7 January 2021

Intranasal antigen targeting to MHC class II molecules primes local IgA and serum IgG antibody responses in mice

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2800%2900487-4

7 January 2021

B cells solicit their own help from T cells.

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2800%2900487-4

7 January 2021

Mucosal immunity and tolerance: relevance to vaccine development

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2800%2900487-4

7 January 2021

Antigen-unspecific B cells and lymphoid dendritic cells both show extensive surface expression of processed antigen-major histocompatibility complex class II complexes after soluble protein exposure in vivo or in vitro.

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2800%2900487-4

7 January 2021

The induction of tolerance by dendritic cells that have captured apoptotic cells

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2800%2900487-4

7 January 2021

Coordinated events during bacteria-induced DC maturation.

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2800%2900487-4

7 January 2021

Cholera toxin induces maturation of human dendritic cells and licences them for Th2 priming

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2800%2900487-4

7 January 2021

The mechanism of cholera toxin adjuvanticity

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2800%2900487-4

7 January 2021

Cholera toxin suppresses interleukin (IL)-12 production and IL-12 receptor beta1 and beta2 chain expression

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2800%2900487-4

7 January 2021

https://api.crossref.org/works/10.1016%2FS0264-410X%2800%2900487-4

1 reference

7 January 2021

Actions of cholera toxin and the prevention and treatment of cholera

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2800%2900487-4

7 January 2021

Cholera toxin and related enterotoxins as potent immune modulators

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2800%2900487-4

7 January 2021

Membrane traffic and the cellular uptake of cholera toxin

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2800%2900487-4

7 January 2021

Cholera toxin and cholera B subunit as oral-mucosal adjuvant and antigen vector systems

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2800%2900487-4

7 January 2021

Mutants of the Escherichia coli heat-labile enterotoxin with reduced ADP-ribosylation activity or no activity retain the immunogenic properties of the native holotoxin.

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2800%2900487-4

7 January 2021

Dissociation of Escherichia coli heat-labile enterotoxin adjuvanticity from ADP-ribosyltransferase activity

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2800%2900487-4

7 January 2021

Genetic detoxification of bacterial toxins: a new approach to vaccine development

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2800%2900487-4

7 January 2021

Mutants in the ADP-ribosyltransferase cleft of cholera toxin lack diarrheagenicity but retain adjuvanticity

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2800%2900487-4

7 January 2021

A nontoxic mutant of cholera toxin elicits Th2-type responses for enhanced mucosal immunity

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2800%2900487-4

7 January 2021

Mucosal adjuvanticity and immunogenicity of LTR72, a novel mutant of Escherichia coli heat-labile enterotoxin with partial knockout of ADP-ribosyltransferase activity

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2800%2900487-4

7 January 2021

A novel concept in mucosal adjuvanticity: the CTA1-DD adjuvant is a B cell-targeted fusion protein that incorporates the enzymatically active cholera toxin A1 subunit

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2800%2900487-4

7 January 2021

Hydrophobicity engineering of cholera toxin A1 subunit in the strong adjuvant fusion protein CTA1-DD

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2800%2900487-4

7 January 2021

The ADP-Ribosylating CTA1-DD Adjuvant Enhances T Cell-Dependent and Independent Responses by Direct Action on B Cells Involving Anti-Apoptotic Bcl-2- and Germinal Center-Promoting Effects

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2800%2900487-4

7 January 2021

Cutting edge: the mucosal adjuvant cholera toxin redirects vaccine proteins into olfactory tissues

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2800%2900487-4

7 January 2021

Dendritic cell survival and maturation are regulated by different signaling pathways.

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2800%2900487-4

7 January 2021

https://api.crossref.org/works/10.1016%2FS0264-410X%2800%2900487-4

1 reference

7 January 2021

10.1016/S0264-410X(00)00487-4

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11257390%20AND%20SRC:MED&resulttype=core&format=json

5 November 2019

1 reference